Summary
A new technique is described for measurement of diffusion across the blood-brain barrier using intraventricularly administered68Ga-EDTA, and determining loss from the brain with a scintillation camera. Repeated injections via permanent cannulas showed that the diffusion half-time was reduced to 50% of control values after intraventricular d-amphetamine and 6-hydroxydopamine; pimozide had no effect.
Similar content being viewed by others
References
A.T. Shulgin, T. Sargent and C. Naranjo, Nature221, 537 (1969).
H.O. Anger and A. Gottschalk, J. nucl. Med.4, 326 (1963).
L.R. Schaer, H.O. Anger and A. Gottschalk, Am. med. Ass.198, 811 (1966).
C.N. Shearly, S. Aronow and G.L. Brownell, J. nucl. Med.5, 161 (1964).
R.L. Hayes in: Radioactive Pharmaceuticals, p. 603. Ed. G.A. Andrews. US Atomic Energy Commission, 1966.
Y. Yano, pp. 117–125, in: Radiopharmaceuticals from generator-produced radionuclides, p. 117. Int. Atomic Energy Agency, Vienna 1971.
L. Stein and C.D. Wise, Science171, 1032, (1971).
W. Soudijn and J. Van Wijngaarden, J. Pharm. Pharmac.24, 773 (1972).
V. Levin and C.S. Patlak, J. Physiol.224, 559, (1972).
Author information
Authors and Affiliations
Additional information
Acknowledgment. This work was supported by the Division of Biomedical and Environmental Research of the US Department of Energy, and the Deutsche Forschungsgemeinschaft.
Rights and permissions
About this article
Cite this article
Braun, U., Braun, G. & Sargent, T. Changes in blood-brain permeability resulting from d-amphetamine, 6-hydroxydopamine and pimozide measured by a new technique. Experientia 36, 207–209 (1980). https://doi.org/10.1007/BF01953735
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01953735